These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29611540)

  • 21. Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice.
    Desai U; Lee EC; Chung K; Gao C; Gay J; Key B; Hansen G; Machajewski D; Platt KA; Sands AT; Schneider M; Van Sligtenhorst I; Suwanichkul A; Vogel P; Wilganowski N; Wingert J; Zambrowicz BP; Landes G; Powell DR
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11766-71. PubMed ID: 17609370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin.
    Shen CJ; Chan SH; Lee CT; Huang WC; Tsai JP; Chen BK
    Cancer Lett; 2017 Feb; 386():110-122. PubMed ID: 27865799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANGPTL4-αvβ3 interaction counteracts hypoxia-induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2.
    Gomez Perdiguero E; Liabotis-Fontugne A; Durand M; Faye C; Ricard-Blum S; Simonutti M; Augustin S; Robb BM; Paques M; Valenzuela DM; Murphy AJ; Yancopoulos GD; Thurston G; Galaup A; Monnot C; Germain S
    J Pathol; 2016 Dec; 240(4):461-471. PubMed ID: 27577973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.
    Dewey FE; Gusarova V; O'Dushlaine C; Gottesman O; Trejos J; Hunt C; Van Hout CV; Habegger L; Buckler D; Lai KM; Leader JB; Murray MF; Ritchie MD; Kirchner HL; Ledbetter DH; Penn J; Lopez A; Borecki IB; Overton JD; Reid JG; Carey DJ; Murphy AJ; Yancopoulos GD; Baras A; Gromada J; Shuldiner AR
    N Engl J Med; 2016 Mar; 374(12):1123-33. PubMed ID: 26933753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angiopoietin-like 4 modulates aldolase A expression in human melanoma cell in a PKC dependent manner].
    Sun Y; Wang X; Fang B; Xiong X; Long J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 40(8):851-7. PubMed ID: 26333492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice.
    Wang Y; Lam KS; Lam JB; Lam MC; Leung PT; Zhou M; Xu A
    Mol Endocrinol; 2007 Apr; 21(4):972-86. PubMed ID: 17213385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiopoietin-like 4 serum levels on admission for acute myocardial infarction are associated with no-reflow.
    Bouleti C; Mathivet T; Serfaty JM; Vignolles N; Berland E; Monnot C; Cluzel P; Steg PG; Montalescot G; Germain S
    Int J Cardiol; 2015; 187():511-6. PubMed ID: 25863293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor gamma expression in peripheral blood mononuclear cells and angiopoietin-like protein 4 levels in obese children and adolescents.
    Sadeghabadi ZA; Nourbakhsh M; Alaee M; Larijani B; Razzaghy-Azar M
    J Endocrinol Invest; 2018 Feb; 41(2):241-247. PubMed ID: 28733963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Castration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed mice.
    Harada N; Hanaoka R; Horiuchi H; Kitakaze T; Mitani T; Inui H; Yamaji R
    Sci Rep; 2016 Mar; 6():23001. PubMed ID: 26961573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of intestinal microbiota does not protect mice from diet-induced obesity.
    Fleissner CK; Huebel N; Abd El-Bary MM; Loh G; Klaus S; Blaut M
    Br J Nutr; 2010 Sep; 104(6):919-29. PubMed ID: 20441670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydrocapsiate supplementation prevented high-fat diet-induced adiposity, hepatic steatosis, glucose intolerance, and gut morphological alterations in mice.
    Baboota RK; Khare P; Mangal P; Singh DP; Bhutani KK; Kondepudi KK; Kaur J; Bishnoi M
    Nutr Res; 2018 Mar; 51():40-56. PubMed ID: 29673543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.
    Georgiadi A; Wang Y; Stienstra R; Tjeerdema N; Janssen A; Stalenhoef A; van der Vliet JA; de Roos A; Tamsma JT; Smit JW; Tan NS; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1529-37. PubMed ID: 23640487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised, controlled, crossover study of the effect of diet on angiopoietin-like protein 4 (ANGPTL4) through modification of the gut microbiome.
    Blædel T; Holm JB; Sundekilde UK; Schmedes MS; Hess AL; Lorenzen JK; Kristiansen K; Dalsgaard TK; Astrup A; Larsen LH
    J Nutr Sci; 2016; 5():e45. PubMed ID: 28620472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum angiopoietin-like 4 is over-expressed in COPD patients: association with pulmonary function and inflammation.
    Wu YQ; Shen YC; Wang H; Zhang JL; Li DD; Zhang X; Wang T; Xu D; Ying BW; Wang LL; Wen FQ
    Eur Rev Med Pharmacol Sci; 2016; 20(1):44-53. PubMed ID: 26813452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation.
    Cinkajzlová A; Mráz M; Lacinová Z; Kloučková J; Kaválková P; Kratochvílová H; Trachta P; Křížová J; Haluzíková D; Škrha J; Papežová H; Haluzík M
    Nutr Diabetes; 2018 Apr; 8(1):21. PubMed ID: 29695708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-caloric artificial sweeteners and the microbiome: findings and challenges.
    Suez J; Korem T; Zilberman-Schapira G; Segal E; Elinav E
    Gut Microbes; 2015; 6(2):149-55. PubMed ID: 25831243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition.
    Okamoto H; Cavino K; Na E; Krumm E; Kim S; Stevis PE; Harp J; Murphy AJ; Yancopoulos GD; Gromada J
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2747-2752. PubMed ID: 28143927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinoma.
    Liao YH; Chiang KH; Shieh JM; Huang CR; Shen CJ; Huang WC; Chen BK
    Oncogene; 2017 Apr; 36(16):2228-2242. PubMed ID: 27797381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of insulin signaling upregulates angiopoietin-like protein 4 through elevated free fatty acids in diabetic mice.
    Mizutani N; Ozaki N; Seino Y; Fukami A; Sakamoto E; Fukuyama T; Sugimura Y; Nagasaki H; Arima H; Oiso Y
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):139-44. PubMed ID: 22068616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.